Michael J. Rogers

Michael Rogers practices at Michael J. Rogers MD in Sebring, Florida.

Michael Rogers' NPI, 1003876053, was assigned on March 24, 2006. Michael Rogers graduated from New York Medical College in 1982. Michael Rogers holds Florida license ME0058778.

Michael Rogers' primary practice is Michael J. Rogers MD, at 721 Us-27 S, Sebring, FL 33870 in Highlands County. The practice phone is (863) 385-7183.

Michael Rogers' primary practice is Michael J. Rogers MD in Sebring, Florida. The medical group on file is Lakeside Dermatology. Dmand AI also links Michael Rogers to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Rogers practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Michael Rogers' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Michael Rogers is board certified in dermatology by the American Board of Dermatology. Dmand AI has Michael Rogers' licenses on file in 3 states: Florida, Michigan and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Michael Rogers treats.

CMS data shows 8,063 Medicare services from Michael Rogers across 29 procedure codes in 2024, for 1,095 Medicare patients. Medicare paid $425,283 for them. Every service was in an office.

CMS counts 1,095 Medicare patients who saw Michael Rogers in 2024. The largest group is 75 to 84, with 518 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Rogers' median patient age at 76, with 53% women.

In 2024, Michael Rogers wrote 2,250 Medicare Part D claims for 941 patients. 96% of them were for generic drugs. CMS names the drug for 2,161 of them, across 25 drugs with 11 or more claims each, at $35,396 in total drug cost. In 2023, CMS named 2,050 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Michael Rogers for performance year 2024, reported individually. Michael Rogers accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,542 procedures of skin biopsy by Michael Rogers, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 42 papers to Michael Rogers, published from 2003 to 2024. 2007 was the busiest year, with 4. The most frequent topics are Diphosphonates, Osteoclasts and Protein Prenylation. Michael Rogers has published most often in J Bone Miner Res. Michael Rogers' most frequent co-authors are Mark Christopher Eagleton, MD, MPH, Michael J. McKenna, MD and Joshua Robert Smith, MD.

CMS Open Payments shows 14 general payments to Michael Rogers from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. VYNE Pharmaceuticals Inc. paid the most, $66.

Dmand AI lists 5 awards for Michael Rogers, most recently Member in 2005.

Michael Rogers graduated from New York Medical College in 1982. Michael Rogers is a member of AOA, AAD, ASDS and FMA.

Michael Rogers is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.